Diorganomagnesium compound

US12565507B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12565507-B2
Application numberUS-202017785952-A
CountryUS
Kind codeB2
Filing dateDec 14, 2020
Priority dateDec 17, 2019
Publication dateMar 3, 2026
Grant dateMar 3, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A diorganomagnesium compound of formula R B —Mg—R A is provided. R B is different from R A , R B comprises a benzene nucleus substituted with a magnesium atom, one of the carbon atoms of the benzene nucleus ortho to the magnesium is substituted with a methyl, an ethyl, an isopropyl or forming a ring with the carbon atom which is its closest neighbour and which is meta to the magnesium. The other carbon atom of the benzene nucleus ortho to the magnesium is substituted with a methyl, an ethyl or an isopropyl. R A is an alkyl, a cycloalkyl or a benzyl, which may be substituted or unsubstituted, which diorganomagnesium compound is other than n-butylmesitylmagnesium. When used as co-catalyst of a metallocene, it makes it possible to increase the functional group content in the synthesis of a functional polymer.

First claim

Opening claim text (preview).

The invention claimed is: 1 . An asymmetric diorganomagnesium compound of formula (I) R B —Mg—R A   (I), R B being different from R A , R B comprising a benzene ring substituted with the magnesium atom, one of the carbon atoms of the benzene ring ortho to the magnesium atom being substituted with a methyl, an ethyl, an isopropyl or forming a ring with the carbon atom which is its closest neighbor and which is meta to the magnesium atom, the other carbon atom of the benzene ring ortho to the magnesium atom being substituted with a methyl, an ethyl or an isopropyl, R A being an alkyl, a cycloalkyl or a benzyl, which may be substituted or unsubstituted, wherein the diorganomagnesium compound is other than n-butylmesitylmagnesium. 2 . The asymmetric diorganomagnesium compound according to claim 1 , in which R A represents an alkyl containing from 2 to 10 carbon atoms. 3 . The asymmetric diorganomagnesium compound according to claim 1 , in which R A represents a linear alkyl. 4 . A process for preparing an asymmetric diorganomagnesium compound of formula R B —Mg—R A , which comprises the placing in contact of an organometallic compound of formula R A M with an organomagnesium agent of formula R B —Mg—X and the reaction of the organometallic compound of formula R A M and of the organomagnesium agent of formula R B —Mg—X, M representing a lithium, sodium or potassium atom, X representing a leaving group, R B being different from R A , R B comprising a benzene ring substituted with the magnesium atom, one of the carbon atoms of the benzene ring ortho to the magnesium atom being substituted with a methyl, an ethyl, an isopropyl or forming a ring with the carbon atom which is its closest neighbor and which is meta to the magnesium atom, the other carbon atom of the benzene ring ortho to the magnesium atom being substituted with a methyl, an ethyl or an isopropyl, R A being an alkyl, a cycloalkyl or a benzyl, which may be substituted or unsubstituted, said diorganomagnesium compound being other than n-butylmesitylmagnesium. 5 . The process according to claim 4 , in which X is a halogen atom. 6 . The process according to claim 4 , in which X is a bromine atom or a chlorine atom. 7 . The process according to claim 4 , in which M represents a lithium atom. 8 . The asymmetric diorganomagnesium compound according to claim 1 , in which the carbon atoms of the benzene ring of R B ortho to the magnesium atom are substituted with a methyl. 9 . The asymmetric diorganomagnesium compound according to claim 2 , in which R A represents an alkyl containing from 2 to 8 carbon atoms. 10 . The process according to claim 6 , in which X is a bromine atom. 11 . The process according to claim 4 , in which, if one of the two carbon atoms of the benzene ring of R B ortho to the magnesium atom is substituted with an isopropyl, the second carbon atom of the benzene ring of R B ortho to the magnesium atom is not substituted with an isopropyl. 12 . The process according to claim 4 , in which the carbon atoms of the benzene ring of R B ortho to the magnesium atom are substituted with a methyl or an ethyl. 13 . A process for preparing an asymmetric diorganomagnesium compound of formula (II) in which R 1 and R 5 represent a methyl or an ethyl, R 2 , R 3 and R 4 , which may be identical or different, represent a hydrogen atom or an alkyl, R A is an alkyl, a cycloalkyl or a benzyl, which may be substituted or unsubstituted, which comprises the placing in contact of an organometallic compound of formula R A M with an organomagnesium agent of formula R B —Mg—X and the reaction of the organometallic compound of formula R A M and of the organomagnesium agent of formula R B —Mg—X, the organomagnesium agent of formula R B —Mg—X being of the formula: M representing a lithium, sodium or potassium atom, and X representing a leaving group, said diorganomagnesium compound of formula (II) being other than n-butylmesitylmagnesium. 14 . An asymmetric diorganomagnesium compound of formula (II) in which R 1 and R 5 represent a methyl or an ethyl, R 2 , R 3 and R 4 , which may be identical or different, represent a hydrogen atom or an alkyl, R A is an alkyl, a cycloalkyl or a benzyl, which may be substituted or unsubstituted said diorganomagnesium compound of formula (II) being other than n-butylmesitylmagnesium. 15 . The asymmetric diorganomagnesium compound according to claim 14 , in which R 1 , R 3 and R 5 are identical. 16 . The asymmetric diorganomagnesium compound according to claim 14 , in which R 2 and R 4 represent a hydrogen atom. 17 . The asymmetric diorganomagnesium compound according to claim 14 , in which R A represents an alkyl containing from 2 to 10 carbon atoms. 18 . The asymmetric diorganomagnesium compound according to claim 17 , in which R A represents an alkyl containing from 2 to 8 carbon atoms. 19 . The asymmetric diorganomagnesium compound according to claim 14 , in which R A represents a linear alkyl. 20 . The asymmetric diorganomagnesium compound according to claim 14 , in which R 1 and R 5 represent a methyl.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12565507B2 cover?
A diorganomagnesium compound of formula R B —Mg—R A is provided. R B is different from R A , R B comprises a benzene nucleus substituted with a magnesium atom, one of the carbon atoms of the benzene nucleus ortho to the magnesium is substituted with a methyl, an ethyl, an isopropyl or forming a ring with the carbon atom which is its closest neighbour and which is meta to the magnesium. The o…
Who is the assignee on this patent?
Michelin & Cie
What technology area does this patent fall under?
Primary CPC classification C08F210/02. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).